Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes

Diabetes

Volumn 46, Issue 11, 1997, Pages 1786-1791

  Anderson, Richard A ^a   Cheng, Nanzheng ^b   Bryden, Noella A ^a   Polansky, Marilyn M ^a   Cheng, Nanping ^b   Chi, Jiaming ^b   Feng, Jinguang ^b  

^a BELTSVILLE HUMAN NUTRITION RESEARCH CENTER   (United States)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CHROMIUM; CHROMIUM PICOLINATE; GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GLUCOSE HOMEOSTASIS; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030695031     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.11.1786     Document Type: Article

References (52)

1. Jeejeebhoy KN, Chu RC, Marliss EB, Greenberg GR: Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr 30:531-538, 1977
2. Freund H, Atamian S, Fischer JE: Chromium deficiency during total parenteral nutrition. JAMA 241:496-498, 1979
3. Brown RO, Forloines-Lynn S, Cross RE, Heizer WD: Chromium deficiency after long-term parenteral nutrition. Dig Dis Sci 31:661-664, 1986
4. Anderson RA: Essentiality of chromium in humans. Sci Total Environ 86:75-81, 1989
5. Anderson RA: Chromium and parenteral nutrition. Nutrition 11:83-86, 1995
6. Verhage AH, Cheong WK, Jeejeebhoy KN: Neurologic symptoms due to possible chromium deficiency in long-term parenteral nutrition that closely mimic metronidazole-induced syndromes. J Parenteral Enterai Nutr 20:123-127, 1996
7. Hopkins LL Jr., Ransome-Kuti O, Majaj AS: Improvements of impaired carbohydrate metabolism by chromium (III) in malnourished infants. Am J Clin Nutr 21:203-211, 1968
8. Gurson CT, Saner G: Effect of chromium on glucose utilization in marasmic protein-calorie malnutrition. Am J Clin Nutr 24:1313-1319, 1971
9. Levine RA, Streeten DHP, Doisy RJ: Effects of oral chromium supplementation on the glucose tolerance of elderly subjects. Metabolism 17:114-125, 1968
10. Glinsmann WH, Mertz W: Effect of trivalent chromium on glucose tolerance. Metabolism 15:510-520, 1966
11. Nath R, Minocha J, Lyall V, Sunder S, Kumar V, Kapoor S, Dhar KL: Assessment of chromium metabolism in maturity onset and juvenile diabetes using chromium-51 and therapeutic response of chromium administration on plasma lipids, glucose tolerance and insulin levels. In Chromium in Nutrition and Metabolism. Shapcott D, Hubert J, Eds. Amsterdam, Elsevier, 1979
12. Mossop RT: Effects of chromium (III) on fasting glucose, cholesterol and cholesterol HDL levels in diabetics. Cent Afr J Med 29:80-82, 1983
13. Ravina A, Siezak L, Rubal A, Mirsky N: Clinical use of the trace element chromium (III) in the treatment of diabetes mellitus. J Trace Elem Exptl Med 8:183-190, 1995
14. Anderson RA, Polansky MM, Bryden NA, Bhathena SJ, Canary J: Effects of supplemental chromium on patients with symptoms of reactive hypoglycemia Metabolism 36:351-355, 1987
15. Clausen J: Chromium induced clinical improvement in symptomatic hypoglycemia J Clin Invest 17:229-236, 1988
16. Anderson RA, Polansky MM, Bryden NA, Canary JJ: Supplemental chromium effects on glucose, insulin, glucagon, and urinary chromium losses in subjects consuming controlled low-chromium diets. Am J Clin Nutr 54:909-916, 1991
17. Anderson RA, Polansky MM, Bryden NA, Roginski EE, Mertz W, Glinsmann WH: Chromium supplementation of human subjects: effects on glucose, insulin and lipid parameters. Metabolism 32:894-899, 1983
18. Doisy RJ, Streeten DHP, Freiberg JM, Schneider AJ: Chromium metabolism in man and biochemical effects. In Trace Elements in Human Health and Disease: Essential and Toxic Elements. Vol. 2. Prasad AS, Oberleas D, Eds. New York, Marcel Dekker, 1976
19. Toman RW, Bilbo JT, Doisy RJ: Comparison and effects of natural and synthetic glucose tolerance factor in normal and genetically diabetic mice. Diabetes 27:49-56, 1978
20. Loft JA, Turner K: Evaluation of Trinder's glucose oxidase method for measuring glucose in serum and urine. Clin Chem 21:1754-1760, 1975
21. Albano JDM, Ekins RP, Maritz G: A sensitive, precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties. Acta Endocrinol 70:487-509, 1972
22. Deacon AC, Dawson PJG: Enzymic assay of total cholesterol involving chemical or enzymic hydrolysis: a comparison of methods. Clin Chem 25:976-984, 1979
23. 2+: polypropylene glycol precipitation both with enzymic cholesterol assay compared with the lipid research method. Am J Clin Nutr 78:718-723, 1982
24. Kohimeier M: Direct enzymic measurement of glycerides in serum and in lipoprotein fractions. Clin Chem 32:63-66, 1986
25. Foster LB, Hockholzer JM: A single-reagent manual method for directly determining urea nitrogen in serum. Clin Chem 17:921-925, 1971
26. Anderson RA: Stress effects on chromium nutrition of humans and farm animals. In: Proceedings of Alltech's Tenth Symposium Biotechnology in the Feed Industry. Nottingham, England, Univ. Press, 1994, p. 267-274
27. Kozlovsky AS, Moser PB, Reiser S, Anderson RA: Effects of diets high in simple sugars on urinary chromium losses. Metabolism 35:515-518, 1986
28. Anderson RA, Bryden NA, Polansky MM, Thorp JW: Effect of carbohydrate loading and underwater exercise on circulating cortisol, insulin and urinary losses of chromium and zinc. Eur J Appl Physiol 63:146-150, 1991
29. Mowat DN, Chang X, Yang WZ: Chelated chromium for stressed feeder calves. Can J Anim Sci 73:49-53, 1993
30. Abraham AS, Brooks BA, Eylath U: The effects of chromium supplementation on serum glucose and lipids in patients with and without non-insulin-dependent diabetes. Metabolism 41:768-771, 1992
31. Sherman L, Glennon JA, Brech WJ, Klomberg GH, Gordon ES: Failure of trivalent chromium to improve hyperglycemia in diabetes mellitus. Metabolism 17:439-442, 1968
32. Rabinowitz MB, Gonick HC, Levine SR, Davidson MB: Clinical trial of chromium and yeast supplements on carbohydrate and lipid metabolism in diabetic men. Biol Trace Elem Res 5:449-466, 1983
33. Uusitupa MIJ, Kumpulainen JT, Voutilainen E, Hersio K, Sarlund H, Pyorala KP, Koivistoinen PE, Lehton JT: Effect of inorganic chromium supplementation on glucose tolerance, insulin response and serum lipids in noninsulin-dependent diabetics. Am J Clin Nutr 38:404-410, 1983
34. Uusitupa MU, Mykkanen L, Sittonen O, Laakso M, Sarlund H, Kolehmainen P, Rasanen T, Kumpulainen J, Pyorala K: Chromium supplementation in impaired glucose tolerance of elderly: effects on blood glucose, plasma insulin, C-peptide and lipid levels. Brit J Nutr 68:209-216, 1992
35. Evans GW: The effect of chromium picolinate on insulin controlled parameters in humans. Int J Biosoc Med Res 11:163-180, 1989
36. Anderson RA, Bryden NA, Polansky MM, Gautschi K: Dietary chromium effects on tissue chromium concentrations and chromium absorption in rats. J Trace Elem Exptl Med 9:11-25, 1996
37. Bunn HF: Evaluation of glycosylated hemoglobin in diabetic patients. Diabetes 30:613-617, 1981
38. MacDonald JM, Davis JE: Glycosylated hemoglobins and diabetes mellitus. Hum Pathol 10:279-291, 1979
39. Mayer TK, Freedman ZR: Protein glycosylation in diabetes mellitus: a review of laboratory measurements and their clinical utility. Clin Chim Acta 127:147-184, 1983
40. Schleicher E, Weitland OH: Protein glycation: measurement and clinical relevance. J Clin Chem Clin Biochem 27:577-587, 1989
41. Takara Y, Shima K: The response of Ghb to stepwise plasma glucose change over time in diabetic patients. Diabetes Care 16:1313-1314, 1993
42. 1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care 18:440-447, 1995
43. Roeback JR Jr., Mae K, Chambless LE, Fletcher RH: Effects of chromium supplementation on serum high-density lipoprotein cholesterol levels in men taking beta-blockers. Ann Inter Med 115:917-924, 1991
44. Mossop RT: Diabetogenic effect of thiazides and the relation to chromium: a preliminary report. Cent Afr J Med 7:129-131, 1985
45. Martinez OB, MacDonald AC, Gibson RS, Bourn O: Dietary chromium and effect of chromium supplementation on glucose tolerance of elderly Canadian women. Nutr Res 5:609-620, 1985
46. Anderson RA, Brantner JH, Polansky MM: An improved assay for biologically active chromium. J Agric Food Chem 26:1219-1221, 1978
47. Mertz W, Toepfer EW, Roginski EE, Polansky MM: Present knowledge of the role of chromium. Fed Proc 33:2275-2280, 1974
48. Anderson RA, Polansky MM, Brantner JH, Roginski EE: Chemical and biological properties of biologically active chromium. In Trace Element Metabolism in Man and Animals. Vol. 3. Kirchgessner M, Ed. Freising-Weihenstephan, Germany, Institut für Ernährungsphysiologie, 1978
49. Potter JF, Levin P, Anderson RA, Freiberg JM, Andres R, Elahi D: Glucose metabolism in glucose-intolerant older people during chromium supplementation. Metabolism 34:199-204, 1985
50. Reaven GM: Role of insulin resistance in human diseases. Diabetes 37:1595-1606, 1988
51. Mertz W, Abernathy CO, Olin SS: Risk Assessment of Essential Elements. Washington, DC, ILSI Press, 1994, p. xix-xxviii
52. Anderson RA, Bryden NA, Polansky MM: Lack of toxicity of chromium chloride and chromium picolinate. J Am Coll Nutr 16:273-279, 1997